Osteochondroprogenitor cells and neutrophils expressing p21 and senescence markers modulate fracture repair

Dominik Saul,Madison L. Doolittle,Jennifer L. Rowsey,Mitchell N. Froemming,Robyn L. Kosinsky,Stephanie J. Vos,Ming Ruan,Nathan LeBrasseur,Abhishek Chandra,Robert Pignolo,João F. Passos,Joshua N. Farr,David G. Monroe,Sundeep Khosla

DOI: https://doi.org/10.1101/2024.02.01.578420

2024-02-07

Abstract:Cells expressing features of senescence, including upregulation of p21 and p16, appear transiently following tissue injury, yet the properties of these cells or how they contrast with age-induced senescent cells remains unclear. Here, we used skeletal injury as a model and identified the rapid appearance following fracture of p21+ cells expressing senescence markers, mainly as osteochondroprogenitors (OCHs) and neutrophils. Targeted genetic clearance of p21+ cells suppressed senescence-associated signatures within the fracture callus and accelerated fracture healing. By contrast, p21+ cell clearance did not alter bone loss due to aging; conversely, p16+ cell clearance, known to alleviate skeletal aging, did not affect fracture healing. Following fracture, p21+ neutrophils were enriched in signaling pathways known to induce paracrine stromal senescence, while p21+ OCHs were highly enriched in senescence-associated secretory phenotype factors known to impair bone formation. Further analysis revealed an injury-specific stem cell-like OCH subset that was p21+ and highly inflammatory, with a similar inflammatory mesenchymal population (fibro-adipogenic progenitors) evident following muscle injury. Thus, intercommunicating senescent-like neutrophils and mesenchymal progenitor cells are key regulators of tissue repair in bone and potentially across tissues. Moreover, our findings establish contextual roles of p21+ p16+ senescent/senescent-like cells that may be leveraged for therapeutic opportunities.

Physiology

What problem does this paper attempt to address?

This paper aims to explore the role of cells expressing p21 and senescence markers during the fracture repair process and their differences from age - related senescent cells. Specifically, the research focuses on the following points:

1. **Cell characteristics and functions**: Using bone injury as a model, the researchers identified cells expressing p21 and senescence markers that rapidly appear after fractures. These cells are mainly osteochondroprogenitor cells (OCHs) and neutrophils. By gene - targeted elimination of p21+ cells, the study found that this can inhibit senescence - related signals in the fracture - healing area and accelerate the fracture - healing process.

2. **Comparison with age - related senescent cells**: The study also compared the effect of p21+ cell elimination on fracture healing with the effect of p16+ cell elimination on age - related bone loss. The results showed that eliminating p21+ cells is beneficial for fracture healing, while eliminating p16+ cells has no obvious effect on fracture healing, but the latter is known to alleviate bone aging.

3. **Cell signaling pathways**: After fractures, p21+ neutrophils are enriched in signaling pathways known to induce paracrine mesenchymal cell senescence, while p21+ OCHs are highly enriched in senescence - associated secretory phenotype factors known to inhibit bone formation.

4. **Similarities across tissues**: Further analysis in the study found that after muscle injury, there are also similar inflammatory mesenchymal progenitor cells expressing p21 (such as fibro - adipogenic progenitor cells FAPs), indicating that this phenomenon may not be limited to bones but is普遍存在 across tissues.

In conclusion, this study reveals the crucial role of cells expressing p21 and senescence markers in fracture healing after tissue injury and their differences from age - related senescent cells, providing a theoretical basis for the development of new treatment strategies.